IVERIC bio Investor Relations Material
Latest events
Q4 2022
IVERIC bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IVERIC bio Inc
Access all reports
IVERIC bio, Inc. is a biopharmaceutical company specializing in the discovery and development of treatments for retinal diseases. The company's focus includes developing therapies for age-related macular degeneration and other ocular conditions that lead to vision loss. IVERIC bio aims to address unmet medical needs in ophthalmology through innovative research and targeted approaches to eye health. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
ISEE
Country
🇺🇸 United States